2025 Analysis: Opportunities and Risks in the Evolving Microbiome Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Microbiome Market Heading Into 2029?
The expansion of the microbiome market has been exponential in the past few years. The market value is anticipated to increase from $0.68 billion in 2024 to $0.82 billion in 2025, indicating a compound annual growth rate (CAGR) of 20.1%. The notable growth in the preceding period can be linked to the escalating demand for immunology, more collaborations, initiatives by the government, higher healthcare spending, and an increase in the number of healthcare facilities.
The size of the microbiome market is projected to experience a significant surge in the forthcoming years, increasing to “$1.43 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%. This anticipated growth within the projected period can be tied to factors like the surge in healthcare spending, the growing demand for personalized medication, increased funding, advancements in technology, and a heightened incidence of chronic diseases. Major upcoming trends within this period encompass the adoption of artificial intelligence, strategic partnerships and agreements to heighten revenues and set up category leadership, an increase in pipeline research aimed at creating microbiome therapies for various diseases, and considering investment in the development of oncology microbiome therapies to ameliorate productivity, efficiency, and precision technology’s accuracy.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3397&type=smp
Which Factors Are Pushing The Microbiome Market Forward?
The growth of the microbiome market is expected to be propelled by the rising prevalence of inflammatory bowel disease (IBD). IBD is a set of chronic inflammatory conditions impacting the digestive tract, mainly the gastrointestinal (GI) tract. The role of the gut microbiome in this disease has gained significant attention. As a result, there has been an increase in research, diagnostics, and treatments focused on the microbiome, leading to the expansion of the microbiome market. In September 2022, The American Gastroenterological Association (AGA), a United States-based association for gastroenterologists, reported that 40% of Americans paused their daily routines due to discomforting bowel symptoms. Further, 60-70 million Americans are battling with gastrointestinal diseases that substantially interrupt their daily lives. This suggests that the rise in IBD’s prevalence will likely stimulate the expansion of the microbiome market.
The microbiome market covered in this report is segmented –
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
What Upcoming Trends Are Expected To Impact The Microbiome Market Globally?
The surge in technological enhancement is a significant trend that’s gaining traction in the microbiome market. Key players in the microbiome industry are directing their efforts towards the creation of sophisticated technology solutions for microbiomes. Seed, a burgeoning microbiome firm introduced Probiotic and Prebiotic Daily Synbiotic that caters to both women and men. The Daily Synbiotic from Seed is novel in its approach of employing a microbe-system strategy, offering strain-specific benefits beyond just digestive health. These include cardiac safety, skin health, immune regulation, reproductive health, gut barrier integrity, and control of oxidative stress.
Which Organizations Are Driving Progress In The Microbiome Industry?
Major companies operating in the microbiome market include Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report
Which Region Is Expected To Experience The Highest Growth In The Microbiome Industry?
North America was the largest region in the microbiome market in 2024. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3397&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
